Zobrazeno 1 - 10
of 180
pro vyhledávání: '"A Widlitz"'
Autor:
Vampola, Christa-Lynn, Fahrbach, Kyle, Huelin, Rachel, Widlitz, Allison, Christal, Kevin, Benton, Wade, Davis, Christopher
Publikováno v:
In Wilderness & Environmental Medicine December 2023 34(4):e4-e4
Autor:
Tapson, Victor F., Gomberg-Maitland, Mardi, McLaughlin, Vallerie V., Benza, Raymond L., Widlitz, Allison C., Krichman, Abigail, Barst, Robyn J.
Publikováno v:
In Chest March 2006 129(3):683-688
Autor:
Kawut, Steven M., Horn, Evelyn M., Berekashvili, Ketevan K., Lederer, David J., Widlitz, Allison C., Rosenzweig, Erika B., Barst, Robyn J.
Publikováno v:
In Pulmonary Pharmacology & Therapeutics 2006 19(5):370-374
Autor:
Kawut, Steven M., Horn, Evelyn M., Berekashvili, Ketevan K., Widlitz, Allison C., Rosenzweig, Erika B., Barst, Robyn J.
Publikováno v:
In Chest October 2005 128(4):2355-2362
Autor:
Kawut, Steven M. *, Horn, Evelyn M., Berekashvili, Ketevan K., Garofano, Robert P., Goldsmith, Rochelle L., Widlitz, Allison C., Rosenzweig, Erika B., Kerstein, Diane, Barst, Robyn J.
Publikováno v:
In The American Journal of Cardiology 2005 95(2):199-203
Publikováno v:
Critical Care Nurse. Apr2007, Vol. 27 Issue 2, p41-50. 8p.
Autor:
Oudiz, Ronald J.1 oudiz@humc.edu, Widlitz, Allison2, Beckmann, X. Joy1, Camanga, Daisy1, Alfie, Jose3, Brundage, Bruce H.4, Barst, Robyn J.2
Publikováno v:
CHEST. Jul2004, Vol. 126 Issue 1, p90-94. 5p.
Publikováno v:
Critical Care Nurse. 27:41-50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::add122c09042a2709868722f94e13ecf
https://doi.org/10.4037/ccn2007.27.2.41
https://doi.org/10.4037/ccn2007.27.2.41
Autor:
Erika B. Rosenzweig, David J. Lederer, Allison C. Widlitz, Steven M. Kawut, Evelyn M. Horn, Robyn J. Barst, Ketevan Berekashvili
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 19:370-374
Background Pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary vascular resistance which leads to right ventricular failure. Serotonin and the serotonin transporter play an important role in animal and human studies of PAH. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1881427b53f04221dc561c4a0ce275b9
https://doi.org/10.1016/j.pupt.2006.01.001
https://doi.org/10.1016/j.pupt.2006.01.001
Autor:
Vallerie V. McLaughlin, Victor F. Tapson, Allison C. Widlitz, Mardi Gomberg-Maitland, Robyn J. Barst, Abigail Krichman, Raymond L. Benza
Publikováno v:
Chest. 129:683-688
Background: Pulmonary arterial hypertension (PAH) is a life-threatening disease for which both continuous IV epoprostenol and continuous subcutaneous treprostinil have proven effective. With continuous IV treprostinil having potential advantages over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0ccbd59d4f1666b59cf7641631e9a31
https://doi.org/10.1378/chest.129.3.683
https://doi.org/10.1378/chest.129.3.683